Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihaly

Showing results (681-690 of 717) with videos related to

Pageof 72
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 9, 2023
Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596Brad A Acker, Valentina O Badescu, Mitchell B Berkenpas, et al.
Journal of Medicinal Chemistry|October 3, 2012
Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitorsMichelle M Claffey, Christopher J Helal, Patrick R Verhoest, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2025
Effects of NAD<sup>+</sup> supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trialZsofia Szarvas, Zeke A Reyff, Anna Peterfi, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Science Translational Medicine|December 6, 2019
Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunctionVladimir V Senatorov, Aaron R Friedman, Dan Z Milikovsky, et al.
Shock (Augusta, Ga.)|February 27, 2014
Abandon the mouse research ship? Not just yet!Marcin F Osuchowski, Daniel G Remick, James A Lederer, et al.
Archives of Dermatological Research|February 20, 2025
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosumTayler Tobey, Alex G Ortega-Loayza, Sharon I Choe, et al.
Journal of Medicinal Chemistry|January 2, 2010
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition modelsChristopher J O'Donnell, Bruce N Rogers, Brian S Bronk, et al.
Gigascience|November 30, 2022
3D-Beacons: decreasing the gap between protein sequences and structures through a federated network of protein structure data resourcesMihaly Varadi, Sreenath Nair, Ian Sillitoe, et al.
Molecular & Cellular Proteomics : MCP|May 21, 2023
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer BiomarkersJozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, et al.
Pageof 72

Showing results (681-690 of 717) with videos related to

Sort By:
Pageof 72
Bioorganic & Medicinal Chemistry Letters|August 9, 2023
Positive allosteric modulators of the α7 nicotinic acetylcholine receptor: SAR investigation around PNU-120596Brad A Acker, Valentina O Badescu, Mitchell B Berkenpas, et al.
Journal of Medicinal Chemistry|October 3, 2012
Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitorsMichelle M Claffey, Christopher J Helal, Patrick R Verhoest, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 6, 2025
Effects of NAD<sup>+</sup> supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trialZsofia Szarvas, Zeke A Reyff, Anna Peterfi, et al.
Chemmedchem|March 21, 2009
Fragment-based identification of Hsp90 inhibitorsJohn J Barker, Oliver Barker, Roberto Boggio, et al.
Science Translational Medicine|December 6, 2019
Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunctionVladimir V Senatorov, Aaron R Friedman, Dan Z Milikovsky, et al.
Shock (Augusta, Ga.)|February 27, 2014
Abandon the mouse research ship? Not just yet!Marcin F Osuchowski, Daniel G Remick, James A Lederer, et al.
Archives of Dermatological Research|February 20, 2025
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosumTayler Tobey, Alex G Ortega-Loayza, Sharon I Choe, et al.
Journal of Medicinal Chemistry|January 2, 2010
Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition modelsChristopher J O'Donnell, Bruce N Rogers, Brian S Bronk, et al.
Gigascience|November 30, 2022
3D-Beacons: decreasing the gap between protein sequences and structures through a federated network of protein structure data resourcesMihaly Varadi, Sreenath Nair, Ian Sillitoe, et al.
Molecular & Cellular Proteomics : MCP|May 21, 2023
Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer BiomarkersJozsef Lazar, Peter Antal-Szalmas, Istvan Kurucz, et al.
Pageof 72